Based on these results, we have shown that ENO1 DNA vaccination prolonged the survival of genetically engineered mice that spontaneously develop PDA by eliciting an integrated humoral and cellular immune response to ENO1 [11]. The gene discussed is ENO1; the disease is Patent ductus arteriosus.